nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain SADBern
|
Haddad, Nadia |
|
1994 |
12 |
4 |
p. 307-309 3 p. |
artikel |
2 |
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
|
Alonso, María J. |
|
1994 |
12 |
4 |
p. 299-306 8 p. |
artikel |
3 |
Calendar
|
|
|
1994 |
12 |
4 |
p. 384- 1 p. |
artikel |
4 |
Composition containing selectively deglycosylated HIV virus-1 envelope protein; deglycosylation by protein engineering for use as a recombinant vaccine
|
|
|
1994 |
12 |
4 |
p. 381- 1 p. |
artikel |
5 |
Defective recombinant adenovirus-2 or adenovirus-5 vector expressing Epstein—Barr virus protein; for use as a recombinant vaccine
|
|
|
1994 |
12 |
4 |
p. 381- 1 p. |
artikel |
6 |
Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice
|
Tamura, Shin-ichi |
|
1994 |
12 |
4 |
p. 310-316 7 p. |
artikel |
7 |
Helicobacter pylori recombinant heat shock protein hsp60, cytotoxin and cytotoxin-associated immunodominant antigen production; DNA sequence, DNA probe, DNA primer and vector; disease diagnosis and therapy and recombinant vaccine
|
|
|
1994 |
12 |
4 |
p. 382- 1 p. |
artikel |
8 |
Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide—ovalbumin conjugate
|
Gilbert, Florence B. |
|
1994 |
12 |
4 |
p. 369-374 6 p. |
artikel |
9 |
Laboratory methods for the conduct of experimental malaria challenge of volunteers
|
Davis, Jonathan R. |
|
1994 |
12 |
4 |
p. 321-327 7 p. |
artikel |
10 |
Live vaccine to getah virus disease for pig protection; attenuation by serial passage in Vero cell culture and production of trivalent vaccine composit
|
|
|
1994 |
12 |
4 |
p. 381- 1 p. |
artikel |
11 |
Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions
|
Ohki, Kohji |
|
1994 |
12 |
4 |
p. 343-350 8 p. |
artikel |
12 |
Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines
|
Peeters, Ben |
|
1994 |
12 |
4 |
p. 375-380 6 p. |
artikel |
13 |
Protection of mice against experimental murine mycoplasmosis by a Mycoplasma pulmonis immunogen in lysogenized Escherichia coli
|
Lai, Wayne C. |
|
1994 |
12 |
4 |
p. 291-298 8 p. |
artikel |
14 |
Purification of antibody—antigen complexes containing recombinant SIV proteins: comparison of antigen and antibody—antigen complexes for immune priming
|
Randall, R.E. |
|
1994 |
12 |
4 |
p. 351-358 8 p. |
artikel |
15 |
Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain
|
Dasgupta, Ujjala |
|
1994 |
12 |
4 |
p. 359-364 6 p. |
artikel |
16 |
Recombinant herpes simplex virus-1 glycoprotein-E; gene cloning and expression in Spodoptera frugiperda insect cell culture using a baculovirus vec
|
|
|
1994 |
12 |
4 |
p. 381- 1 p. |
artikel |
17 |
Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies
|
|
|
1994 |
12 |
4 |
p. 382- 1 p. |
artikel |
18 |
Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador
|
Sempértegui, Fernando |
|
1994 |
12 |
4 |
p. 337-342 6 p. |
artikel |
19 |
SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission
|
Teuscher, T. |
|
1994 |
12 |
4 |
p. 328-336 9 p. |
artikel |
20 |
Sudden infant death syndrome (SIDS): are common bacterial toxins responsible, and do they have a vaccine potential?
|
Murrell, Timothy G.C. |
|
1994 |
12 |
4 |
p. 365-368 4 p. |
artikel |
21 |
Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern
|
Lafay, Florence |
|
1994 |
12 |
4 |
p. 317-320 4 p. |
artikel |